Feedback

Application of high-dose tranexamic acid in the perioperative period: a narrative review

Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Duan, Yushan;
Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Wan, Xiaohong;
Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Ma, Yiming;
Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Zhu, Weihua;
Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Yin, Yue;
Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Huang, Qingqing;
Affiliation
Department of Critical Care Medicine ,The Second Affiliated Hospital ,Kunming Medical University ,Kunming ,China
Yang, Yuan

Objective To investigate the efficacy and safety of high-dose tranexamic acid in different types of surgeries and provide a reference for clinical practice. Methods We systematically searched PubMed, Cochrane Library, Science, Embase, and CNKI databases, from their inception to January 2025, to include representative literature related to high-dose tranexamic acid in the perioperative period for a thematic synthesis. The analysis focused on clinical evidence related to obstetric, cardiac, urologic, orthopedic, and spinal surgeries. Results High-dose tranexamic acid markedly reduces blood loss and transfusion requirements in most types of surgery; however, the optimal dose varies by surgery type. Available studies have shown a favorable safety profile; however, some areas (e.g., cardiac surgery) still require careful monitoring for seizures and risk of thrombotic events. Conclusion The clinical benefit of high-dose tranexamic acid should be assessed based on surgical characteristics and patient individualization. More multicenter studies are needed to clarify the dose-effect relationship and long-term safety.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 Duan, Wan, Ma, Zhu, Yin, Huang and Yang.

Use and reproduction: